跳至主要内容
临床试验/JPRN-jRCT2080221188
JPRN-jRCT2080221188未知2 期

Phase II Study of ME3738 prolonged administration in Chronic Hepatitis C patients.

MEIJI SEIKA KAISHA, LTD.0 个研究点开始时间: 2010年8月6日最近更新:
适应症

试验速览

阶段
2 期

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • The patients who are completed 48 weeks administration for the Phase II Study of ME3738 in Chronic Hepatitis C Patients.

排除标准

  • - The patients who exihibited some clinically problemed adverse events.

研究者

相似试验

进行中(未招募)
3 期
Phase III Clinigal Study of ME3208 in Patients with cGVHDChronic graft versus host disease
JPRN-jRCT2011210041Kijima Koji20
未知
3 期
M518101 phase III 52-Week long term study in plaque psoriasis and palmoplantar keratoderma patientsPlaque psoriasis and palmoplantar keratoderma
JPRN-jRCT2080222895Maruho Co.,Ltd.
进行中(未招募)
不适用
A phase III long-term follow-up study to assess immunological memory induced following primary and booster vaccination with GSK Biologicals’ 10-valent pneumococcal conjugate vaccine (10Pn-PD-DiT), through evaluation of early antibody responses after an additional dose of 10Pn-PD-DiT at 40-48 months of age, to evaluate in the fourth year of life, the immunogenicity and safety of a 2-dose catch-up immunization course with the 10Pn-PD-DiT vaccine and the impact of pneumococcal vaccination on nasopharyngeal carriage. - 10PN-PD-DIT-042 EXT 014Subjects aged 31-44 months previously vaccinated with GSK Biologicals’ 10Pn-PD-DiT vaccine and age-matched unprimed children who participated in study 10PN-PD-DIT-014 (107137).
EUCTR2008-008104-41-CZGlaxoSmithKline Biologicals690
进行中(未招募)
1 期
Study of LY3410738 Administered to Patients with Advanced Solid Tumors with IDH1 or IDH2 Mutations
JPRN-jRCT2031200178Takeshi Masaki15
进行中(未招募)
1 期
A Phase 3b Study to Evaluate the Duration of Effect of Bimatoprost SR in Participants with Open-Angle Glaucoma or Ocular Hypertensio
EUCTR2018-002574-52-BGAbbVie Deutschland GmbH & Co. KG490